Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes.
Faraoni I, Consalvo MI, Aloisio F, Fabiani E, Giansanti M, Di Cristino F, Falconi G, Tentori L, Di Veroli A, Curzi P, Maurillo L, Niscola P, Lo-Coco F, Graziani G, Voso MT.
Faraoni I, et al. Among authors: curzi p.
Cancers (Basel). 2019 Sep 16;11(9):1373. doi: 10.3390/cancers11091373.
Cancers (Basel). 2019.
PMID: 31527467
Free PMC article.